The SELLAS Life Sciences Group Inc. (SLS) shares are trading at higher $3.56 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $12.44 and the low is $1.46. Over the last 52 weeks, SLS is down -71.38% while the S&P 500 is up 0.79%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, SLS reported a profit of $79000.0. SELLAS Life Sciences Group Inc. also saw revenues decrease to $4.06 million. In addition, SLS has free cash flow of -$6.83 million as of 03-2020. The company’s EBITDA came in at -$4.06 million which compares well with its peers.
SLS Return on Equity (ROE) is -278.00%, and its Return on Assets is -135.70%. All told, it is clear that, SLS needs to be on your watchlist.
Find out when SLS reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. SLS has a short ratio of 1.16 and outstanding shares of 6.38M.
SLS has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.48 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -11.21. SELLAS Life Sciences Group Inc. SLS also noted assets of $17.03 million at the end of the last quarter. Investors should also keep an eye on sector updates as SLS has historically followed its peers on positive news.
All told, SELLAS Life Sciences Group Inc. SLS has strung together solid data and demonstrated underlying fundamentals. At its current valuation, SLS represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
SELLAS Life Sciences Group Inc. SLS is now commanding a market cap of 21.61M and a float of 6.29M. SLS is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of SLS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in SLS, either long or short, and we have not been compensated for this article.